Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002996859 | SCV003313859 | likely benign | not provided | 2022-07-09 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV005351069 | SCV006023108 | uncertain significance | Inborn genetic diseases | 2025-01-22 | criteria provided, single submitter | clinical testing | The c.932G>A (p.R311Q) alteration is located in exon 6 (coding exon 5) of the KAT6A gene. This alteration results from a G to A substitution at nucleotide position 932, causing the arginine (R) at amino acid position 311 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |